Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Identify index funds with top risk-adjusted returns to guide smarter allocations. Learn criteria for selecting high-efficiency funds.
28,465 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Tariff-Related Lawsuits Could Hurt Costco Stock Now examines how legal challenges tied to tariffs can affect a retail...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
Housing stocks depression mode is taking hold as major builders and appliance makers slump despite a rising S&P 500. ...
Galaxy Research analyst Alex Thorn lifts the odds of the CLARITY Act becoming law in 2026 to 75%, citing a pivotal Se...
Crypto traders wager on SpaceX ahead of its Nasdaq debut, driving more than $1 billion in SPCX perpetual futures over...
Equifax will keep VantageScore 4.0 at $1 through 2027, a move that could reshape mortgage lending as lenders race to ...
This in-depth look at Repositrak (TRAK) 2026 earnings breaks down the drivers behind revenue growth, margin trends, a...
If SpaceX ever hits the public markets, the big question isn’t rocket tech or Starlink alone. It’s whether the compan...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
When the broader market stumbled, CoreWeave stock surged higher this week thanks to AI cloud demand and solid custome...